In addition to APOE and three causal early onset AD genes (APP, PSEN1, PSEN2), genome-wide studies have identified variations in 24 loci that are associated with sporadic late onset AD, strongly implicating inflammation pathways in the molecular etiology of the disease [5]. This evidence concerns the gene PSEN2 and Alzheimer disease.